Wed, March 16, 2022
Tue, March 15, 2022
Mon, March 14, 2022

Tejas Savant Maintained (AKYA) at Buy with Decreased Target to $19 on, Mar 15th, 2022

Tejas Savant of Morgan Stanley, Maintained "Akoya Biosciences, Inc." (AKYA) at Buy with Decreased Target from $20 to $19 on, Mar 15th, 2022.

Tejas, nor any peers, have made any analyst calls on AKYA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30